JUN and cancer: For 25 BRAFV600E melanoma lines in the Cancer Cell Line Encyclopedia (Barretina et al, 2012), we also observed a statistically significant correlation between JUN expression levels and PLX4720 sensitivity (Spearman's ρ = 0.47, P = 0.02; see below; Supplementary Fig S2P).